NEW ORLEANS -- In an interview at the Society of Nuclear Medicine and Molecular Imaging annual meeting, Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, discussed new appropriate use criteria for amyloid and tau PET imaging in Alzheimer’s disease patients.
Video from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelines
Latest in Molecular Imaging
Stanford pulls in Atley and Telix for At-211 supply in western U.S.
February 13, 2026
Siemens Healthineers, Mayo Clinic expand collaboration
February 12, 2026
Journal of Nuclear Medicine names new editor in chief
February 11, 2026




















